(919) 224-8800 Contact Our Team

Clinical trial participation rates are especially low among adult minorities and underserved populations in spite of their bearing a disproportionate burden of disease.  The gap in representative enrollment limits the knowledge base for determining the effectiveness and safety of strategies for treating cancer.  

Who Should Listen:  Trial sponsors, clinicians, R&D, and site personnel wanting to learn more about barriers to trial participation common to minority and underserved oncology patient populations.

What You'll Learn:  Join our panel of experts for this interactive presentation on improving enrollment rates among monitory and underserved oncology patient populations as they relate to stages of a conceptual model of the enrollment process, including:

  • Awareness of clinical trials
  • Opportunities to join specific trials
  • Deciding to enroll


  • Barb Geiger, BSN, RN
    EVP, Oncology and Latin America, Clinipace Worldwide
  • Mark Shapiro
    Executive Director of Clinical Development, Clinipace Worldwide

Free Webcast:

Building a Framework for Equity Enrollment in Oncology Trials

Download the webcast now!